KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stryker (SYK) Accumulated Expenses (2016 - 2025)

Stryker (SYK) has disclosed Accumulated Expenses for 17 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 13.68% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 13.68% year-over-year, with the annual reading at $1.6 billion for FY2025, 13.68% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $1.6 billion at Stryker, up from $1.3 billion in the prior quarter.
  • The five-year high for Accumulated Expenses was $1.6 billion in Q4 2025, with the low at $689.0 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $1.0 billion, with a median of $952.5 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses soared 68.56% in 2021, then decreased 12.47% in 2022.
  • Over 5 years, Accumulated Expenses stood at $1.1 billion in 2021, then increased by 5.22% to $1.1 billion in 2022, then rose by 28.63% to $1.5 billion in 2023, then decreased by 5.07% to $1.4 billion in 2024, then rose by 13.68% to $1.6 billion in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $1.6 billion, $1.3 billion, and $1.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.